Daniel Stauder
Stock Analyst at JMP Securities
(4.22)
# 465
Out of 5,006 analysts
18
Total ratings
64.71%
Success rate
14.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Market Outperform | $33 → $42 | $40.75 | +3.07% | 5 | Aug 8, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $34.73 | +72.76% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $2.83 | +147.35% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $87.49 | +25.73% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $721.59 | +0.47% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $11.58 | - | 1 | May 7, 2024 |
Artivion
Aug 8, 2025
Maintains: Market Outperform
Price Target: $33 → $42
Current: $40.75
Upside: +3.07%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $34.73
Upside: +72.76%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $2.83
Upside: +147.35%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $87.49
Upside: +25.73%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $721.59
Upside: +0.47%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $11.58
Upside: -